Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CD45RA Depleted DLI After Haploidentical HCT
NCT05943067Phase 2Recruiting
- Sponsor
- University Hospital Tübingen
- Start
- Apr 2023
- Primary completion
- Jan 2028
- Modality
- Adoptive Cell Transfer
- Countries
- 1
01
Overview
A Phase 2 trial of CD45RA depleted donor lymphocyte infusion in hematologic malignancy, sponsored by University Hospital Tübingen. Started Apr 2023; status: recruiting.
02
Drugs
CD45RA depleted donor lymphocyte infusion
03
Conditions
hematologic malignancy
Beyond the preview
Go deeper on NCT05943067.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05943067.